These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4455519)

  • 1. Antibacterial activity of aminosidine and of beta-lactamic antibiotics.
    Sanfilippo A; Mazzoleni R
    Farmaco Prat; 1974 Jan; 29(1):21-6. PubMed ID: 4455519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiological points of view on the response of enteropathogenic strains of E. coli to ampicillin, paromomycin, gentamycin, cephalothin and nalidixic acid].
    Teodorovici G; Zvorişteanu V; Oană C; Ioan E; Ivan A; Groll M; Dănăilă F; Năstase A
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(1):103-8. PubMed ID: 4895226
    [No Abstract]   [Full Text] [Related]  

  • 3. On the spectrum of the antimicrobial activity of aminosidine, with a comment on the methods usually employed to test the bacteriostatic and bactericidal action of antibiotics "in vitro".
    Buogo A; Cattaneo P
    Panminerva Med; 1973; 15(11-12):415-23. PubMed ID: 4806253
    [No Abstract]   [Full Text] [Related]  

  • 4. [Compared sensitivities to cephalothin cephaloridine cephalexin and ampicillin of 500 bacterial strains isolated in a hospital].
    Courtieu AL; Sedallian A; Moinard D; Lecluse J
    Pathol Biol (Paris); 1972 Jan; 20(1):43-50. PubMed ID: 4552029
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility of clinical strains of bacteria to cefoxitin.
    Bremner DA
    N Z Med J; 1981 Sep; 94(691):173-4. PubMed ID: 6945507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological activity in vitro and in vivo of cephazolin (author's transl).
    Renzini G; Ravagnan G; Oliva B; Salvetti ME
    Antibiotica; 1973 Mar; 11(1):5-21. PubMed ID: 4806552
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current methods of determination of the sensitivity of bacteria to antibiotics and their significance for rational antibiotic therapy].
    Gauze GF
    Antibiotiki; 1969 Oct; 14(10):952-7. PubMed ID: 4311307
    [No Abstract]   [Full Text] [Related]  

  • 8. [New semisynthetic aminosidine derivatives].
    Arcamone FM; Cassinelli G; Julita P; Rossi U; Schioppacassi G; Mazzoleni R; Sanfilippo A; Ciferri O
    G Ital Chemioter; 1977; 24(1-2):77-81. PubMed ID: 615766
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cephaloridine activity on bacterial flora isolated from non-specific bronchopneumonic processes].
    Curci G; Ninni A
    Policlinico Med; 1971; 78(6):284-9. PubMed ID: 5157402
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance types in Escherichia coli. I. Occurrence and resistance to ampicillin, carbenicillin and cephalothin.
    Søgaard P
    Acta Pathol Microbiol Scand B; 1979 Aug; 87(4):235-41. PubMed ID: 386710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In-vitro antibacterial activity of an aminoglucoside antibiotic: lividomycin A].
    Marmo E; Cazzola M; Brita G; Paciello C
    Arch Monaldi; 1975; 30(4):287-310. PubMed ID: 1047630
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial susceptibility of enterobacteriaceae and nonfermenting gram-negative bacilli.
    Washington JA
    Mayo Clin Proc; 1969 Nov; 44(11):811-24. PubMed ID: 4310745
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selection of chemotherapeutic agents for the resistance determination of fast growing bacteria (minimal requirements)].
    Dtsch Med Wochenschr; 1972 Feb; 97(8):303-4. PubMed ID: 4333596
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative sensitivity of 207 strains of strict anaerobic bacteria to piperacillin and 4 other antibiotics].
    Reynaud A; Drugeon HB; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 Nov; 33(9):891-5. PubMed ID: 3909081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.
    Isenberg HD; Sampson-Scherer J; Cleeland R; Titsworth E; Beskid G; Christenson JG; DeLorenzo WF; Unowsky J
    Crit Rev Microbiol; 1982; 10(1):1-76. PubMed ID: 6756787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cephalosporins: past and future.
    Verbist L
    Acta Clin Belg; 1979; 34(3):165-78. PubMed ID: 506625
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].
    Schmid E; Price P; Krech U
    Arzneimittelforschung; 1974 Sep; 24(9):1256-8. PubMed ID: 4373015
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro antibacterial activity of new oxime type of beta-lactam antibiotics].
    Holá V; Adensamová J; Mandel M
    Cesk Farm; 1990 Sep; 39(7):302-4. PubMed ID: 2098202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)].
    Shah PM; Schirmer KP; Helm EB; Stille W
    Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.